Andrew D Dickinson Gilead Sciences, Inc. (GILD) insider trading activity

Andrew D Dickinson is Chief Financial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 132,373 shares of GILD, which is worth approximately $12.4 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 8,500 shares (Common Stock) at a price of $91.96 per share, resulting in proceeds of $781,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

4.71% 3M change

24.25% 12M change

Total Value Held $12.4 Million

Andrew D Dickinson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	SELL Open market or private sale	$781,660 $91.96 p/Share	8,500 Reduced 6.03%	132,373 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$155,685 $92.34 p/Share	1,686 Reduced 1.18%	140,873 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	3,640 Added 2.49%	142,559 Common Stock
Nov 29 2024	SELL Open market or private sale	$23,064,310 $92.76 p/Share	248,645 Reduced 64.16%	138,919 Common Stock
Nov 29 2024	BUY Exercise of conversion of derivative security	$17,310,664 $69.62 p/Share	248,645 Added 39.08%	387,564 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$136,982 $81.44 p/Share	1,682 Reduced 1.2%	138,919 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	3,641 Added 2.52%	140,601 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$108,445 $65.25 p/Share	1,662 Reduced 1.2%	136,960 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	3,639 Added 2.56%	138,622 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$338,415 $75.12 p/Share	4,505 Reduced 3.23%	134,983 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	9,732 Added 6.52%	139,488 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$1,832,066 $78.26 p/Share	23,410 Reduced 15.32%	129,436 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	74,961 Added 32.91%	152,846 Common Stock
Jan 16 2024	SELL Open market or private sale	$428,900 $85.78 p/Share	5,000 Reduced 4.69%	101,534 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$94,349 $79.02 p/Share	1,194 Reduced 1.11%	106,534 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	2,617 Added 2.37%	107,728 Common Stock
Nov 10 2023	SELL Payment of exercise price or tax liability	$61,039 $75.92 p/Share	804 Reduced 0.76%	105,111 Common Stock
Nov 10 2023	BUY Exercise of conversion of derivative security	-	1,912 Added 1.77%	105,915 Common Stock
Oct 17 2023	SELL Open market or private sale	$400,000 $80.0 p/Share	5,000 Reduced 4.59%	104,003 Common Stock
Sep 10 2023	SELL Payment of exercise price or tax liability	$91,428 $76.0 p/Share	1,203 Reduced 1.09%	109,003 Common Stock
Sep 10 2023	BUY Exercise of conversion of derivative security	-	2,619 Added 2.32%	110,206 Common Stock
Jul 20 2023	SELL Open market or private sale	$400,000 $80.0 p/Share	5,000 Reduced 4.44%	107,587 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$95,228 $78.12 p/Share	1,219 Reduced 1.63%	73,701 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	2,618 Added 3.38%	74,920 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$385,495 $79.5 p/Share	4,849 Reduced 4.18%	111,188 Common Stock

ADD

Andrew D Dickinson

Chief Financial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account